Artizen Corporation ("Artizen") is a diversified asset management company that was founded to acquire, develop, and support companies and technologies in the emerging cannabis industry. Artizen primarily does so in Washington state today, where it generates revenue by providing leasing, licensing, management, staffing, and supplies to cannabis production facilities. Artizen's existing clients operate five licensed cannabis cultivation and processing facilities in Washington, with about 120,000 square feet of canopy, of which only about 50,000 square feet is currently used. Most of the biomass produced by those facilities has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state.
The company also has a 5% equity stake in KRTL Biotech which has KFDA approval to develop medicines in South Korea by using magic mushrooms..
Pervasip Corp.. is traded on the OTC under the ticker symbol PVSP. This is not investment advice. Please view the disclaimer found on this website.
